Skip to content…
NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis
Cancer Diagnosis Program | Biorepositories and Biospecimen Research Branch
Biospecimen Research Database help |
  • Home
  • Search
    • Advanced Search
    • Browse by Analyte
    • Browse by Pre-analytical Factor
    • Search SOPs
    • SOP Compendiums
  • Suggest a New Paper
  • Submit an SOP
  • Curator Home
  • Back Office
  • Citing BRD
  • BBRB
Advanced SearchBrowse by AnalyteBrowse by Pre-analytical FactorSearch SOPsSOP Compendiums

Most Recently Added

2026-05-13 Pre-analytical sample handling standardization for reliable measurement of metabolites and lipids in LC-MS-based clinical research.
2026-05-12 Optimization of DNA extraction and sampling methods for successful forensic microbiome analyses of the skin and saliva.
2026-05-11 Metabolic and lipidomic stability in EDTA plasma from hospitalized patients: impact of refrigerated storage time and additional freeze-thaw cycle.
2026-05-07 Comparison of pre-analytical properties of blood collection systems for the diagnosis of diabetes mellitus.
2026-05-07 Adapting clinical chemistry plasma as a source for liquid biopsies.
2026-05-06 Comparative Liquid Biopsy Testing for KRAS Mutations From Plasma Cell-Free DNA (cfDNA) and Extracellular Vesicles in Lung Adenocarcinoma.
2026-05-05 Comparative evaluation of two different blood collection tubes for hematological and biochemical testing.
2026-05-05 Pre-analytical stability of blood samples transported by drone versus ground: a pilot study.
2026-05-04 Elecsys CSF AD immunoassays: Sample stability for a new pre-analytical protocol for fresh CSF.
2026-05-04 Preanalytical study concerning the influence of tube type and centrifugation conditions on the concentration of calprotectin in ascites.
2026-02-04 ctDNA transiting into urine is ultrashort and facilitates noninvasive liquid biopsy of HPV+ oropharyngeal cancer.
2025-11-25 Effect of Delayed Centrifugation on the Levels of NMR-Measured Lipoproteins and Metabolites in Plasma and Serum Samples.
2025-11-19 Influence of hemolysis, lipemia and bilirubin on biobank sample quality- origin and interference in the use for extracellular vesicle (EV) and MiRNA analyses.
2025-11-17 Frozen section histopathology and preanalytical factors affecting nucleic acid integrity in biobanked fresh-frozen human cancer tissues.
2025-11-13 Quality Control of RNA Extracted from PAXgene® Blood RNA Tubes after Long-Term Cryopreservation.
2025-11-12 Impact of pre-analytical variables - temperature, agitation, storage duration, and blood-to-anticoagulant ratio - on complete blood count test reliability.
2025-11-12 Serum and Plasma miRNA Expression Levels in Sudden Sensorineural Hearing Loss.
2025-11-10 Short- and medium-term pre-analytical stability of human serum insulin-like growth factor-1.
2025-11-06 Systematic comparison of quantity and quality of RNA recovered with commercial FFPE tissue extraction kits.
2025-11-05 Evaluation of urinary cfDNA workflows for the molecular profiling of malignant disease.
2025-11-04 Optimization and comparison of genomic DNA extraction from whole blood collected in PAXgene blood RNA tube using automated platforms.
2025-10-23 Comparison of enzymatic and bisulfite conversion of circulating cell-free tumor DNA for DNA methylation analyses.
2025-10-22 Impact of Centrifugation Time Reduction in GLP Systems.
2025-10-21 Selected miRNAs in Urinary Extracellular Vesicles Show Promise for Early and Specific Diagnostics of Diabetic Kidney Disease.
2025-10-16 Comparative Evaluation of Centrifugation Speed and Its Impact on Diagnostic Accuracy.
2025-10-15 Cell free RNA detection of pancreatic cancer in pre diagnostic high risk and symptomatic patients.
2025-10-14 Urinary microbiome in non-muscle invasive bladder cancer: impact of sample types and sex differences.
2025-10-09 Robustness of urinary extracellular vesicle-derived MiRNA profiles over multiple days and the impact of urine concentration.
2025-10-07 Comparative DNA extraction methods to use for LAMP assay as molecular diagnosis of human schistosomes from urine samples.
2025-10-06 Analysis of urine cell-free DNA copy number and fragment size from healthy individuals.
2025-09-25 The effect of inadequate drying of blood spots on newborn screening analyte concentrations.
2025-09-24 Refined Procedure to Purify and Sequence Circulating Cell-Free DNA in Prostate Cancer.
2025-09-22 Analysis of genome-wide 5-hydroxymethylation of blood samples stored in different anticoagulants: opportunities for the expansion of clinical resources for epigenetic research.
2025-09-17 Stability of microRNAs in serum and plasma reveal promise as a circulating biomarker.
2025-09-16 Impact of ambient temperature exposure on miRNA stability in human plasma.
2025-09-04 Evaluation of pre-analytical factors impacting urine test strip and chemistry results.
2025-09-02 Faecal amino acids stability: investigating optimal sampling conditions for analysis.
2025-08-28 Effects of certain pre-analytical factors on the performance of plasma phospho-tau217.
2025-08-26 Surgical Tumor Resection Deregulates Hallmarks of Cancer in Resected Tissue and the Surrounding Microenvironment.
2025-08-18 EDTA tubes are suitable for insulin and C-peptide measurement in resource-limited settings and can be stored at room temperature for up to 24 hours.
2025-08-18 The influence of hemolysis in patient samples on biochemical tests analyzed using Roche Cobas® 8000 Analyzer.
2025-08-08 Standardized Workflow and Analytical Validation of Cell-Free DNA Extraction for Liquid Biopsy Using a Magnetic Bead-Based Cartridge System.
2025-08-06 Impact of Long-Term Plasma Storage on Cell-Free DNA Epigenetic Biomarker Studies.
2025-08-04 A comparative study of four cell-free DNA assays for detecting circulating tumor DNA in early breast cancer.
2025-07-27 Rapid one-step protocol for exploring immune cells in cerebrospinal fluid.
2025-07-08 Evaluation of variability in cell-free DNA extraction efficiency from plasma and urine and spike-in normalization.
2025-07-02 Preanalytical stability of 17 analytes in whole blood during transportation.
2025-06-24 Challenges in circulating miRNA analysis in adrenocortical tumors.
2025-06-24 Storage Time and DNA Quality Determine BRCA1/2 Sequencing Success in Prostate Cancer: A Multicentre Analysis with Therapeutic Implications.
2025-06-16 RNA degradation patterns in cardiac tissues kept at different time intervals and temperatures before RNA sequencing.
BBRB Home Contact Us Acknowledgment Disclaimer Policy Accessibility FOIA HHS Vulnerability Disclosure BRD Curator Login
A Service of the National Cancer Institute
  • U.S. Department of Health and Human Services
  • National Institutes of Health
  • National Cancer Institute
  • USA.gov
NIH… Turning Discovery Into Health®
BRD v3.3.19